Quest Diagnostics
DGX
#1219
Rank
$14.73 B
Marketcap
$133.11
Share price
1.56%
Change (1 day)
-4.09%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Total assets

Total assets on the balance sheet as of December 2023 : $14.02 B

According to Quest Diagnostics 's latest financial reports the company's total assets are $14.02 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Quest Diagnostics - Total assets on balance sheet (from 2001 to 2023)

Total assets by year

Year Total assets Change
2023-12-31$14.02 B9.23%
2022-12-31$12.83 B-5.69%
2021-12-31$13.61 B-2.96%
2020-12-31$14.02 B9.21%
2019-12-31$12.84 B16.72%
2018-12-31$11.00 B4.76%
2017-12-31$10.50 B3.99%
2016-12-31$10.10 B1.39%
2015-12-31$9.96 B1.07%
2014-12-31$9.85 B10.16%
2013-12-31$8.94 B-3.62%
2012-12-31$9.28 B-0.32%
2011-12-31$9.31 B9.21%
2010-12-31$8.52 B-0.42%
2009-12-31$8.56 B1.9%
2008-12-31$8.40 B-1.89%
2007-12-31$8.56 B51.3%
2006-12-31$5.66 B6.7%
2005-12-31$5.30 B26.22%
2004-12-31$4.20 B-2.27%
2003-12-31$4.30 B29.4%
2002-12-31$3.32 B13.43%
2001-12-31$2.93 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
$16.72 B 19.28%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
$14.1 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.68 B-88.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.11 B-56.39%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$99.07 M-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA